Success Metrics

Clinical Success Rate
100.0%

Based on 17 completed trials

Completion Rate
100%(17/17)
Active Trials
2(9%)
Results Posted
12%(2 trials)

Phase Distribution

Ph early_phase_1
1
4%
Ph not_applicable
10
43%
Ph phase_1
7
30%
Ph phase_3
2
9%
Ph phase_4
3
13%

Phase Distribution

8

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution23 total trials
Early Phase 1First-in-human
1(4.3%)
Phase 1Safety & dosage
7(30.4%)
Phase 3Large-scale testing
2(8.7%)
Phase 4Post-market surveillance
3(13.0%)
N/ANon-phased studies
10(43.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

17 of 17 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

23

all time

Status Distribution
Active(4)
Completed(17)
Other(2)

Detailed Status

Completed17
unknown2
Not yet recruiting2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.3%)
Phase 17 (30.4%)
Phase 32 (8.7%)
Phase 43 (13.0%)
N/A10 (43.5%)

Trials by Status

unknown29%
not_yet_recruiting29%
completed1774%
recruiting14%
active_not_recruiting14%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT07515664Phase 4

Vitamin K for Perioperative Warfarin Management

Recruiting
NCT05891119Early Phase 1

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

Completed
NCT05505552Not Applicable

Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis:

Active Not Recruiting
NCT07041645Not Applicable

Bioavailability of Different Vitamin K Vitamers Studied Using 13C-labelled Vitamin K Vitamers

Not Yet Recruiting
NCT06855953Not Applicable

Vitamin K and Cognition in Coronary Heart Disease (NutriCog)

Not Yet Recruiting
NCT00336232Not Applicable

Determinants of Vitamin K Metabolism

Completed
NCT05742295Phase 4

Prevention of Cefoperazone-induced Coagulopathy

Completed
NCT02740712Phase 1

Pharmacokinetic Drug-Drug Interaction Study of Rucaparib

Completed
NCT04285450Not Applicable

The Clinical Effect of Vitamin K Administration in Type 2 Diabetic Patients

Completed
NCT04984083Not Applicable

Maternal and Neonatal Benefits of Prophylactic Administration of Vitamin K Before Elective Cesarean Section

Completed
NCT03941535Phase 4

Comparison of Vitamin K Doses in Patients With Larger Burn Injuries

Unknown
NCT02278692Not Applicable

Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy

Completed
NCT01517399Phase 1

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

Completed
NCT03363815Phase 1

A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

Completed
NCT01462318Phase 3

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

Completed
NCT01636557Phase 1

A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis

Completed
NCT01400646Phase 1

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

Completed
NCT02243553Phase 1

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

Completed
NCT02182336Phase 1

Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

Completed
NCT01910142Not Applicable

Effect of Nutrition on Bone Metabolism as Assessed by 41Ca

Completed

Drug Details

Intervention Type
DRUG
Total Trials
23